Recommendations from the iSBTc-SITC/FDA/NCI Workshop on Immunotherapy Biomarkers

PURPOSE: To facilitate development of innovative immunotherapy approaches, especially for treatment concepts exploiting the potential benefits of personalized therapy, there is a need to develop and validate tools to identify patients who can benefit from immunotherapy. Despite substantial effort, w...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Butterfield, Lisa H., Palucka, A. Karolina, Britten, Cedrik M., Dhodapkar, Madhav V., Håkansson, Leif, Janetzki, Sylvia, Kawakami, Yutaka, Kleen, Thomas-Oliver, Lee, Peter P., Maccalli, Cristina, Maecker, Holden T., Maino, Vernon C., Maio, Michele, Malyguine, Anatoli, Masucci, Giuseppe, Pawelec, Graham, Potter, Douglas M., Rivoltini, Licia, Salazar, Lupe G., Schendel, Dolores J., Slingluff, Craig L., Song, Wenru, Stroncek, David F., Tahara, Hideaki, Thurin, Magdalena, Trinchieri, Giorgio, van Der Burg, Sjoerd H., Whiteside, Theresa L., Wigginton, Jon M., Marincola, Francesco, Khleif, Samir, Fox, Bernard A., Disis, Mary L.
פורמט: Artigo
שפה:Inglês
יצא לאור: 2011
נושאים:
Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3096674/
https://ncbi.nlm.nih.gov/pubmed/21558394
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-10-2234
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים